Trial Profile
A Randomized, Double-Blinded, Vehicle-Controlled Phase IIa Study to Evaluate Topically Applied WBI-1001 Cream in Patients With Atopic Dermatitis.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Tapinarof (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Welichem Biotech
- 30 Oct 2014 New trial record